Evidence map›Paper›PMID 41028778›Full record

ArticleNature communications2025

TP63 mediates the generation of tumour-specific chromatin loops that underlie MYC activation in radiation-induced tumorigenesis.

Qiaowei Liu, Shuai Jiang, Xiang Xu, Kang Xu, Yawen Luo, Zongyuan Yu, Meida Xiang, Zhouyang Xu, Lijie Wang, Sujie Zhang and 13 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. JACS Au · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Qiaowei Liu *Department of Oncology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, 100071, China.
Shuai Jiang *Nanhu Laboratory, State Key Laboratory of Biomedical Analysis (SKLBA, formerly known as National Center of Biomedical Analysis, NCBA), Beijing, 100039, P.R. China.
Xiang Xu *Academy of Military Medical Sciences, Beijing, 100850, P. R. China.
Kang XuAcademy of Military Medical Sciences, Beijing, 100850, P. R. China.
Yawen LuoAcademy of Military Medical Sciences, Beijing, 100850, P. R. China.
Zongyuan YuAcademy of Military Medical Sciences, Beijing, 100850, P. R. China.
Meida XiangAcademy of Military Medical Sciences, Beijing, 100850, P. R. China.
Zhouyang XuBeijing Institute of Radiation Medicine, Beijing, 100850, P. R. China.ORCID http://orcid.org/0000-0002-7047-7889
Lijie WangDepartment of Oncology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, 100071, China.
Sujie ZhangDepartment of Oncology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, 100071, China.
Haitao TaoDepartment of Oncology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, 100071, China.
Xuhui YangDepartment of Oncology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, 100071, China.
Chongbo JiangDepartment of Oncology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, 100071, China.
Xiaoguang QiDepartment of Oncology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, 100071, China.
Hao LiBeijing Institute of Radiation Medicine, Beijing, 100850, P. R. China.ORCID http://orcid.org/0000-0002-9464-1372
Yiming GaoDepartment of Oncology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, 100071, China.
Yao LiDepartment of Oncology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, 100071, China.
Shihui FuDepartment of Cardiology, Hainan Hospital of Chinese People's Liberation Army General Hospital, Sanya, 572013, P. R. China.ORCID http://orcid.org/0000-0001-6707-9049
Pingkun ZhouBeijing Institute of Radiation Medicine, Beijing, 100850, P. R. China.
Xiaochen BoAcademy of Military Medical Sciences, Beijing, 100850, P. R. China.ORCID http://orcid.org/0000-0003-1911-7922
Hebing ChenAcademy of Military Medical Sciences, Beijing, 100850, P. R. China. chb-1012@163.com.ORCID http://orcid.org/0000-0003-4102-356X
Xiaohua ChenBeijing Institute of Radiation Medicine, Beijing, 100850, P. R. China. chenxh0676@sina.com.
Yi HuDepartment of Oncology, the Fifth Medical Center, Chinese PLA General Hospital, Beijing, 100071, China. huyi301zlxb@sina.com.ORCID http://orcid.org/0000-0001-9319-5692

Funding

China Postdoctoral Science Foundation No. 2022T150786
6 · The paper itself

Abstract

Alterations in 3D chromatin conformation may disrupt the interplay between promoters and distal enhancers. How gene regulatory circuits are reshaped during ionizing radiation-induced tumorigenesis remains unclear, and little is known about the mediators that drive these processes. To decipher the chromatin alterations in radiation-induced lung cancer, we performed ATAC-seq, RNA-seq and Hi-C analyses of human bronchial epithelial cells and corresponding radiation-induced malignantly transformed cell lines. We found that this malignant transformation is accompanied by chromatin switching from the inactive B compartment to the active A compartment, an increased number of TADs and gained ATAC-seq peaks that mediate new distal chromatin contacts. We identified tumour protein 63 (TP63) as a mediator of new chromatin-accessible sites that anchor tumour-specific chromatin contacts in radiation-induced tumour cells. A TP63-mediated accessible chromatin site anchors a tumour-specific TAD boundary and multiple tumour-specific chromatin loops, which might underlie MYC oncogene activation during malignant transformation.

Indexed as

CarcinogenesisCell Transformation, NeoplasticChromatinLung NeoplasmsNeoplasms, Radiation-InducedProto-Oncogene Proteins c-mycTranscription FactorsTumor Suppressor ProteinsCell Line, TumorEpithelial CellsGene Expression Regulation, NeoplasticHumansChromatinMYC protein, humanProto-Oncogene Proteins c-mycTP63 protein, humanTranscription FactorsTumor Suppressor Proteins

Identifiers

PMID41028778
PMCPMC12484796

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.